Latest SLNO reports update at 2024-05-09: 2024-Q12023-Q42023-Q1
Soleno Therapeutics logo
Soleno Therapeutics SLNO
$ 47.64 2.98%

Soleno Therapeutics Financial Ratios 2011-2024 | SLNO

Annual Financial Ratios Soleno Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.7 -0.1 -6.3 -3.6 -2.7 -1.0 -1.1 -0.8 -0.1 - - -

P/S

- - - - - - 9.0 32.6 - - - -

EPS

-2.9 -5.8 -0.4 -0.9 -0.6 -1.7 -5.1 -1.7 -10.4 -6.9 - -

EV (Enterprise Value)

18.9 M -1.66 M 126 M 112 M 25.7 M 11 M 12.5 M 12.1 M 12.5 M 38.2 M 36.7 M -

EBITDA per Share

-2.67 -5.56 -0.377 -0.622 -0.561 -0.899 -4.35 -6.39 -20.2 - - -

EV/EBITDA

0.1 -3.6 -4.2 -1.1 0.2 -0.8 -0.6 1.2 - - -

PEG

-0.0 -0.0 -0.32 0.09 -0.04 -0.02 -0.03 -0.01 0.0 - - -

P/B

1.7 0.1 3.4 7.4 1.2 0.6 3.8 3.9 -0.2 - - -

P/CF

-0.8 -0.1 -6.2 -6.3 -3.1 -1.6 -1.0 -1.2 -0.4 - - -

ROE %

-232.58 -173.72 -54.10 -205.89 -43.85 -59.04 -351.22 -493.47 134.28 - - -

ROA %

-90.83 -86.94 -37.92 -80.62 -30.90 -40.15 -216.81 -193.98 -165.25 - - -

ROCE %

-235.77 -177.19 -56.68 -69.85 -33.28 -25.96 -352.82 -242.78 -72.61 - - -

Current Ratio

1.6 2.0 5.8 4.3 13.1 10.4 2.2 2.0 6.5 - - -

DSO

- - - - - - 33.5 147.0 - - - -

DIO

- - - - - - 159.7 570.3 - - - -

DPO

- - - - - - 130.1 719.3 - - - -

Operating Cycle

- - - - - - 193.3 717.3 - - - -

Cash Conversion Cycle

- - - - - - 63.2 -2.0 - - - -

All numbers in USD currency

Quarterly Financial Ratios Soleno Therapeutics

2024-Q1 2023-Q4 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.59 - -0.81 -0.88 - -0.76 -0.72 -1.07 - -1.53 -0.14 -0.11 - -0.11 -0.16 -0.13 - 0.03 -0.31 -0.22 - -0.13 -0.35 -0.19 - -1.71 -0.42 -0.57 - -0.87 -0.23 -220 - -0.33 0.25 -1.67 - -10.42 -5.21 -10.42 - -2.97 - - - - - - - - - -

EBITDA per Share

-0.63 - - -0.84 - -0.59 -0.62 -0.99 - -1.28 -0.13 -0.11 - -0.08 -0.22 -0.2 - -0.15 -0.15 -0.14 - -0.11 -0.12 -0.15 - -0.17 -0.25 -0.25 - -0.62 -0.14 - - -0.31 -0.4 -0.35 - -2.43 -2.41 -1.26 - -1.79 - - - - - - - - - -

ROE %

-467.97 -425.18 -465.52 -430.43 -95.09 -135.38 -135.33 -142.26 -104.17 -122.93 -101.40 -77.57 -47.83 -41.89 -17.18 -67.92 -108.04 -117.04 -131.98 -88.23 -44.71 -58.83 -63.95 -55.70 -39.96 -120.01 -185.95 -273.27 -275.17 -377.34 -399.45 -238.82 -405.31 -287.00 -66.53 -6.59 354.91 359.11 245.00 126.70 4.20 4.20 - - - - - - - - - -

ROA %

-110.22 -89.34 -108.51 -99.37 -50.87 -70.00 -69.95 -74.23 -57.44 -70.59 -64.62 -53.45 -33.53 -31.20 -15.72 -30.58 -42.31 -48.65 -57.32 -47.45 -31.51 -41.21 -44.58 -38.39 -27.27 -76.69 -116.40 -169.36 -169.85 -210.00 -200.74 -114.68 -159.29 -316.96 -434.47 -615.08 -473.01 -573.20 -515.72 -358.05 -100.19 -100.19 - - - - - - - - - -

ROCE %

- -41.02 -82.04 -115.42 -96.22 -137.23 -137.23 -144.25 -105.79 -123.04 -99.27 -83.45 -62.20 -103.24 -127.02 -140.06 -111.96 -124.71 -96.43 -70.03 -35.40 -45.21 -42.27 -42.23 -26.17 -83.46 -130.94 -186.57 -248.21 -303.34 -301.17 -282.86 -113.94 -102.11 -35.16 -5.06 -16.20 -13.57 -22.77 -4.38 2.62 2.62 - - - - - - - - - -

Current Ratio

6.6 7.8 1.7 1.2 1.6 1.9 2.2 2.6 2.0 1.9 2.3 3.0 3.3 3.3 3.3 3.3 1.6 1.6 1.6 1.6 3.4 3.4 3.4 3.4 3.2 3.2 3.1 3.1 2.6 2.6 2.6 2.6 1.6 1.0 0.5 0.4 0.4 - 0.4 0.4 - - - - - - - - - - - -

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - 5155.6 19.5 - 19.4 3102.5 29.5 - 57.6 146.8 323.5 - - - - - 2.3 - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - 1107.0 186.7 - 168.9 1282.9 119.8 - 897.8 2285.4 1673.8 - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - 1375.3 227.8 - 94.0 849.0 122.0 - 1132.5 2882.7 4262.9 - - - - - - - - - - - - - - - -

Operating Cycle

- - - - - - - - - - - - - - - - - - - - - - - - - - 6262.6 206.1 - 188.3 4385.4 149.4 - 955.5 2432.2 1997.3 - - - - - 2.3 - - - - - - - - - -

Cash Conversion Cycle

- - - - - - - - - - - - - - - - - - - - - - - - - - 4887.3 -21.7 - 94.3 3536.4 27.3 - -177.0 -450.5 -2265.6 - - - - - 2.3 - - - - - - - - - -

All numbers in USD currency